Novel Agent Reduces Bowel Movement Frequency in Carcinoid Syndrome
$ 19.00 · 4.9 (446) · In stock
Full article: Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study
Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives
Shifting Paradigms in the Pathophysiology and Treatment of Carcinoid Crisis
Drugs for constipation and diarrhea
Cancers, Free Full-Text
Changes in Weight Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome - ScienceDirect
Frontiers Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review
JCM, Free Full-Text
Cureus, Early Definitive Diagnosis and Management of Incidental Neuroendocrine Tumors Found on Gastrointestinal Endoscopy
Fibrosis and carcinoid syndrome: from causation to future therapy
Molecules, Free Full-Text
Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome, Journal of Patient-Reported Outcomes
Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs), Clinical Diabetes and Endocrinology
Carcinoid syndrome and its sequelae - ScienceDirect